MENUNews Archive
Date: 02/01/2012
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Rogel Cancer Center researchers.
Date: 01/26/2012
Researchers at the University of Michigan, led by Max Wicha, M.D., have found that Avastin, Sutent increase breast cancer stem cells. This could explain the limited success of anti-angiogenesis treatments in breast cancer.
Date: 01/21/2012
University of Michigan is first U.S. academic site to put GE's Veo, which greatly reduces the amount of radiation exposure and therefore, cancer risk, into clinical use.
Date: 01/18/2012
Pavan Reddy, M.D., associate professor of hematology/oncology at the U-M Medical School, was the senior researcher who discovered alpha-1-antitrypsin -- a natural enzyme -- reduces intense inflammation after bone marrow transplant.
Date: 01/16/2012
Researchers at the University of Michigan have found that matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body.
Date: 01/14/2012
In a new study, a program known as Spatially Invariant Vector Quantization (SIVQ) separated a malignancy from background tissue in digital slides of a type of bladder cancer whose features can vary widely and presents diagnostic challenges even for experts.
Date: 01/11/2012
Cancer Center clinics and infusion will reopen Thursday, Jan. 12, as well as all phlebotomy and radiology services on Level B2.
Date: 01/10/2012
Some Cancer Center care will be temporarily relocated or rescheduled; all other patient care continues normally.
Date: 08/04/2011
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Rogel Cancer Center and the Michigan Center for Translational Pathology finds.
Date: 04/29/2011
Researchers at the University of Michigan Rogel Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease.